Myriad Genetics: landmark ruling for gene patenting
11:40 EDT 20 Aug 2012 | BioNews
In the latest instalment of a highly contested case, the US Federal Circuit Court of Appeals in Washington DC upheld Myriad Genetics' right to patent two genes, BRCA1 and BRCA2,which are associated with the risk of breast and ovarian cancer....
Original Article: Myriad Genetics: landmark ruling for gene patenting
More From BioPortfolio on "Myriad Genetics: landmark ruling for gene patenting"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
